TY  - GEN
AU  - Akaza,Hideyuki
AU  - Kawahara,Norie
AU  - Roh,Jae Kyung
AU  - Inoue,Hajime
AU  - Park,Eun-Cheol
AU  - Lee,Kwang-Sig
AU  - Kim,Sukyeong
AU  - Hayre,Jasdeep
AU  - Naidoo,Bhash
AU  - Wilkinson,Thomas
AU  - Fukuda,Takashi
AU  - Jang,Woo Ick
AU  - Nogimori,Masafumi
TI  - Japanese Cancer Association Meeting UICC International session--what is cost-effectiveness in cancer treatment?
SN  - 2476-762X
PY  - 2014///1112
KW  - Antineoplastic Agents
KW  - economics
KW  - Cost-Benefit Analysis
KW  - Drug Costs
KW  - Drug Discovery
KW  - England
KW  - Health Services Accessibility
KW  - Humans
KW  - Japan
KW  - Neoplasms
KW  - drug therapy
KW  - Prescription Fees
KW  - Republic of Korea
KW  - Technology Assessment, Biomedical
N1  - Publication Type: Congress
UR  - https://doi.org/10.7314/apjcp.2014.15.1.3
ER  -